glp-1 medication with insurance coverage just changed for as many as 56 million Americans when it comes to the popular medications used to promote weight loss. link in bio 🔗 Upcoming Insurance Changes for GLP-1

Image Credit: azimmytws / Shutterstock.com A recent BMJ study determines whether the use of glucagon-like peptide-1 (GLP-1) receptor agonists by type 2 diabetes (T2D) patients increases the risk of self-harm, suicidal ideation, and suicide as compared to patients prescribed dipeptidyl peptidase-4 (DPP-4) or sodium-glucose cotransporter-2 (SGLT-2) inhibitors

As the central organ of cholesterol metabolism, the liver directly affects the bodys cholesterol metabolism homeostasis

It is designed for people who may benefit from medical support alongside lifestyle changes

Despite their growing prominence in digital health and obesity management, insurance coverage remains inconsistent

How Foundayo Weight Loss Results Compare With the Wegovy Pill By the end of the study, people on the highest dose lost an average of about 27 pounds (12.4 percent of their starting body weight), compared with average weight loss of just 2.2 pounds with the placebo